Chronic hepatitis e virus infection is specifically associated with an interferon-related transcriptional program

Journal of Infectious Diseases

Volumn 207, Issue 1, 2013, Pages 125-132

  Moal, Valérie ^a,d,e   Textoris, Julien ^d,e   Amara, Amira Ben ^d,e   Mehraj, Vikram ^d,e   Berland, Yvon ^a,b,e   Colson, Philippe ^c,d,e   Mege, Jean Louis ^d,e  

^a Centre de Néphrologie et Transplantation Rénale   (France)

^b Centre d'Investigation Clinique   (France)

^c ASSISTANCE PUBLIQUE HÔPITAUX DE MARSEILLE   (France)

^d AIX MARSEILLE UNIVERSITÉ   (France)

^e AIX MARSEILLE UNIVERSITY   (France)

Author keywords

Chronic hepatitis; EPSTI1; Hepatitis E virus; IFI44L; IFIT1; Interferonstimulated genes; ISG15; Kidney transplantation; Microarray; RSAD2

Indexed keywords

2',5' OLIGOADENYLATE SYNTHETASE; 2',5' OLIGOADENYLATE SYNTHETASE 2; 2',5' OLIGOADENYLATE SYNTHETASE 3; AZATHIOPRINE; CYCLOSPORIN; GAMMA INTERFERON INDUCIBLE PROTEIN 10; HERC5 PROTEIN; INTERFERON; INTERFERON INDUCED PROTEIN WITH TETRATRICOPEPTIDE REPEAT 1; INTERFERON INDUCED PROTEIN WITH TETRATRICOPEPTIDE REPEAT 2; INTERFERON INDUCED PROTEIN WITH TETRATRICOPEPTIDE REPEAT 3; INTERFERON INDUCED PROTEIN WITH TETRATRICOPEPTIDE REPEAT 5; ISG15 PROTEIN; LIGASE; MYCOPHENOLIC ACID; MYXOVIRUS RESISTANCE PROTEIN; PREDNISONE; S ADENOSYLMETHIONINE; STROMAL INTERACTION MOLECULE 1; TACROLIMUS; TETRATRICOPEPTIDE REPEAT PROTEIN; UBIQUITIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DOWN REGULATION; EPSTI1 GENE; FEMALE; GENE; GENE EXPRESSION; GENETIC TRANSCRIPTION; GRAFT RECIPIENT; HEPATITIS E; HEPATITIS E VIRUS; HUMAN; IFI44L GENE; IFIT1 GENE; ISG15 GENE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MALE; MICROARRAY ANALYSIS; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RSAD2 GENE; UPREGULATION;

ADULT; AGED; CASE-CONTROL STUDIES; FEMALE; FRANCE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, VIRAL; HEPATITIS ANTIBODIES; HEPATITIS E; HEPATITIS E VIRUS; HEPATITIS, CHRONIC; HUMANS; INTERFERONS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; UP-REGULATION;

EID: 84872940043     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jis632     Document Type: Article

References (48)

1. Reyes GR, Purdy MA, Kim JP, et al. Isolation of a cDNA from the virus responsible for enterically transmitted non-A, non-B hepatitis. Science 1990; 247:1335-9.
2. Dalton HR, Bendall R, Ijaz S, Banks M. Hepatitis E: an emerging infection in developed countries. Lancet Infect Dis 2008; 8:698-709.
3. Purcell RH, Emerson SU. Hepatitis E: an emerging awareness of an old disease. J Hepatol 2008; 48:494-503.
4. Kamar N, Selves J, Mansuy JM, et al. Hepatitis E virus and chronic hepatitis in organ-transplant recipients. N Engl J Med 2008; 358:811-7.
5. Gerolami R, Moal V, Colson P. Chronic hepatitis E with cirrhosis in a kidney-transplant recipient. N Engl J Med 2008; 358:859-60.
6. Haagsma EB, van den Berg AP, Porte RJ, et al. Chronic hepatitis E virus infection in liver transplant recipients. Liver Transpl 2008; 14:547-53.
7. Haagsma EB, Niesters HG, van den Berg AP, et al. Prevalence of hepatitis E virus infection in liver transplant recipients. Liver Transpl 2009; 15:1225-8.
8. Pischke S, Suneetha PV, Baechlein C, et al. Hepatitis E virus infection as a cause of graft hepatitis in liver transplant recipients. Liver Transpl 2010; 16:74-82.
9. Legrand-Abravanel F, Kamar N, Sandres-Saune K, et al. Hepatitis E virus infection without reactivation in solid-organ transplant recipients, France. Emerg Infect Dis 2011; 17:30-7.
10. Kamar N, Garrouste C, Haagsma EB, et al. Factors associated with chronic hepatitis in patients with hepatitis E virus infection who have received solid organ transplants. Gastroenterology 2011; 140:1481-9.
11. Kamar N, Mansuy JM, Cointault O, et al. Hepatitis E virus-related cirrhosis in kidney- and kidney-pancreas-transplant recipients. Am J Transplant 2008; 8:1744-8.
12. Kamar N, Rostaing L, Abravanel F, et al. Ribavirin therapy inhibits viral replication on patients with chronic hepatitis E virus infection. Gastroenterology 2010; 139:1612-8.
13. Mallet V, Nicand E, Sultanik P, et al. Brief Communication: Case reports of ribavirin treatment for chronic hepatitis E. Ann Intern Med 2010; 153:85-9.
14. Dalton HR, Bendall RP, Keane FE, Tedder RS, Ijaz S. Persistent carriage of hepatitis E virus in patients with HIV infection. N Engl J Med 2009; 361:1025-7.
15. Colson P, Dhiver C, Poizot-Martin I, Tamalet C, Gerolami R. Acute and chronic hepatitis E in patients infected with human immunodeficiency virus. J Viral Hepat 2011; 18:227-8.
16. Kamar N, Abravanel F, Selves J, et al. Influence of immunosuppressive therapy on the natural history of genotype 3 hepatitis-E virus infection after organ transplantation. Transplantation 2010; 89:353-60.
17. Suneetha PV, Pischke S, Schlaphoff V, et al. Hepatitis E virus (HEV)- specific T-cell responses are associated with control of HEV infection. Hepatology 2012; 55:695-708.
18. Yu C, Boon D, McDonald SL, et al. Pathogenesis of hepatitis E virus and hepatitis C virus in chimpanzees: similarities and differences. J Virol 2010; 84:11264-78.
19. Colson P, Borentain P, Queyriaux B, et al. Pig liver sausage as a source of hepatitis E virus transmission to humans. J Infect Dis 2010; 202:825-34.
20. Thuny F, Textoris J, Amara AB, et al. The gene expression analysis of blood reveals S100A11 and AQP9 as potential biomarkers of infective endocarditis. PLoS One 2012; 7:e31490.
21. Culhane AC, Thioulouse J, Perriere G, Higgins DG. MADE4: an R package for multivariate analysis of gene expression data. Bioinformatics 2005; 21:2789-90.
22. Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A 2001; 98:5116-21.
23. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Statist Soc B 1995; 57:289-300.
24. Dennis G Jr., Sherman BT, Hosack DA, et al. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 2003; 4:3.
25. Ashburner M, Ball CA, Blake JA, et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 2000; 25:25-9.
26. Apweiler R, Attwood TK, Bairoch A, et al. InterPro - an integrated documentation resource for protein families, domains and functional sites. Bioinformatics 2000; 16:1145-50.
27. Kanehisa M, Goto S, Kawashima S, Nakaya A. The KEGG databases at GenomeNet. Nucleic Acids Res 2002; 30:42-6.
28. Okuda S, Yamada T, Hamajima M, et al. KEGG Atlas mapping for global analysis of metabolic pathways. Nucleic Acids Res 2008; 36: W423-6.
29. Untergasser A, Nijveen H, Rao X, Bisseling T, Geurts R, Leunissen JA. Primer3Plus, an enhanced web interface to Primer3. Nucleic Acids Res 2007; 35:W71-4.
30. Ben Amara A, Ghigo E, Le Priol Y, et al. Coxiella burnetii, the agent of Q fever, replicates within trophoblasts and induces a unique transcriptional response. PLoS One 2010; 5:e15315.
31. Samarajiwa SA, Forster S, Auchettl K, Hertzog PJ. INTERFEROME: the database of interferon regulated genes. Nucleic Acids Res 2009; 37:D852-7.
32. Neville L, Mathiak G, Bagasra O. The immunobiology of interferongamma inducible protein 10kD (IP-10): a novel, pleiotropic member of the C-X-C chemokine superfamily. Cytokine & Growth Factor Reviews 1997; 8:207-19.
33. Liu MT, Chen BP, Oertel P, et al. The T cell chemoattractant IFNinducible protein 10 is essential in host defense against viral-induced neurologic disease. J Immunol 2000; 165:2327-30.
34. Sadler AJ, Williams BR. Interferon-inducible antiviral effectors. Nat Rev Immunol 2008; 8:559-68.
35. Okumura A, Lu G, Pitha-Rowe I, Pitha PM. Innate antiviral response targets HIV-1 release by the induction of ubiquitin-like protein ISG15. Proc Natl Acad Sci U S A 2006; 103:1440-5.
36. Pichlmair A, Lassnig C, Eberle CA, et al. IFIT1 is an antiviral protein that recognizes 5'-triphosphate RNA. Nat Immunol 2011; 12:624-30.
37. Kitamura A, Takahashi K, Okajima A, Kitamura N. Induction of the human gene for p44, a hepatitis-C-associated microtubular aggregate protein, by interferon-alpha/beta. Eur J Biochem 1994; 224:877-83.
38. Schoggins JW, Wilson SJ, Panis M, et al. A diverse range of gene products are effectors of the type I interferon antiviral response. Nature 2011; 472:481-5.
39. Zou B, Chim CS, Pang R, et al. XIAP-associated factor 1 (XAF1), a novel target of p53, enhances p53-mediated apoptosis via post-translational modification. Mol Carcinog 2011; 51:422-32.
40. Su ZZ, Lee SG, Emdad L, et al. Cloning and characterization of SARI (suppressor of AP-1, regulated by IFN). Proc Natl Acad Sci U S A 2008; 105:20906-11.
41. Taniguchi T, Takaoka A. The interferon-alpha/beta system in antiviral responses: a multimodal machinery of gene regulation by the IRF family of transcription factors. Curr Opin Immunol 2002; 14:111-6.
42. Nielsen HL, Ronnov-Jessen L, Villadsen R, Petersen OW. Identification of EPSTI1, a novel gene induced by epithelial-stromal interaction in human breast cancer. Genomics 2002; 79:703-10.
43. de Neergaard M, Kim J, Villadsen R, et al. Epithelial-stromal interaction 1 (EPSTI1) substitutes for peritumoral fibroblasts in the tumor microenvironment. Am J Pathol 2010; 176:1229-40.
44. Dong C, Mohammad Z, Mixson-Hayden T, et al. Suppression of alpha interferon signaling by hepatitis E virus. Hepatology 2011; 55:1324-32.
45. Sarasin-Filipowicz M, Oakeley EJ, Duong FH, et al. Interferon signaling and treatment outcome in chronic hepatitis C. Proc Natl Acad Sci U S A 2008; 105:7034-9.
46. Dill MT, Duong FH, Vogt JE, et al. Interferon-induced gene expression is a stronger predictor of treatment response than IL28B genotype in patients with hepatitis C. Gastroenterology 2011; 140:1021-31.
47. Chen L, Borozan I, Feld J, et al. Hepatic gene expression discriminates responders and nonresponders in treatment of chronic hepatitis C viral infection. Gastroenterology 2005; 128:1437-44.
48. Tokumoto Y, Hiasa Y, Uesugi K, et al. Ribavirin regulates hepatitis C virus replication through enhancing interferon-stimulated genes and interleukin 8. J Infect Dis 2012; 205:1121-30.